Key facts
- This page summarizes Daniel MacLachlan's Form 4 filing for Red Violet, Inc. (RDVT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 May 2022, 19:08.
Daniel MacLachlan - 02 May 2022 Form 4 Insider Report for Red Violet, Inc. (RDVT)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- RDVT
- Reported as of
- 02 May 2022
- Net transaction value
- -$737,177
- SEC form
- 4
- Accepted by SEC
- 04 May 2022, 19:08:05 UTC
- Prior SEC filing
- 14 Feb 2022
- Next SEC filing
- 26 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel MacLachlan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel MacLachlan filed Form 4 for Red Violet, Inc. (RDVT) on 04 May 2022.
Change
- Previous filing in this sequence was filed on 14 Feb 2022.
- Current net transaction value: -$737,177.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RDVT
transaction
Common Stock
Award
- Transaction value
- Shares
- +100,000
- Change %
- +35%
- Price
- Shares after
- 381,920
- Date
- 02 May 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F3, F4, F5
RDVT
transaction
Common Stock
Tax liability
- Transaction value
- $737,177
- Shares
- -28,266
- Change %
- -7.4%
- Price
- $26.08
- Shares after
- 353,654
- Date
- 02 May 2022
- Ownership
- Direct
- Footnotes
- F3, F4, F5, F6
RDVT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 466
- Date
- 02 May 2022
- Ownership
- Held in IRA
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
A performance grant of Restricted Stock Units (RSUs), which is convertible into common stock of the Company on a one-for-one basis, was approved by the Company's Compensation Committee on October 28, 2019 (the "Performance Grant"), subject to the Performance Criteria described in footnote 2, and described in the Company's definitive proxy statements filed in 2020, 2021 and 2022. On May 2, 2022, the Company's Compensation Committee deemed the Performance Criteria satisfied. In addition to the Performance Criteria, the RSUs were subject to annual time vesting on September 1, 2020, September 1, 2021 and September 1, 2022. As a result, the reporting person was issued 66,667 shares of common stock on May 2, 2022 and 33,333 RSUs remain unvested (as described in footnote 5).
Footnote F2
The Performance Criteria shall be for any fiscal quarter in which the RSUs are outstanding, such RSU shall not vest unless and until the Company has (i) gross revenue determined in accordance with the Company's reviewed or audited financial statements in excess of $12.5 million for such fiscal quarter and positive adjusted EBITDA of at least $2.0 million, and (ii) the recipient continues to provide services to the Company either as an employee, director or consultant on the last day of the quarter that the performance criteria is met. In the event of a change of control, all RSUs which have not vested on the date of such change of control shall immediately vest even if the Performance Criteria have not been met.
Footnote F3
Includes 20,000 RSUs originally granted on November 20, 2020, convertible into common stock of the issuer on a one-for-one basis, which vest in two equal installments on each of November 1, 2022, and November 1, 2023, subject to accelerated vesting under certain conditions.
Footnote F4
Includes 32,500 RSUs originally granted on September 24, 2021, convertible into common stock of the issuer on a one-for-one basis, which vest in three equal installments on each of October 1, 2022, October 1, 2023 and October 1, 2024, subject to accelerated vesting under certain conditions.
Footnote F5
Includes 33,333 RSUs originally granted on October 28, 2019, convertible into common stock of the issuer on a one-for-one basis, which vests on September 1, 2022, subject to accelerated vesting under certain conditions.
Footnote F6
Represents the disposition to issuer for tax obligations upon the vesting of RSUs.